332 related articles for article (PubMed ID: 30582762)
61. The enigma and challenges of vitiligo pathophysiology and treatment.
Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
[TBL] [Abstract][Full Text] [Related]
62. Absence of Merkel cells in lesional skin of vitiligo [corrected].
Bose SK
Int J Dermatol; 1994 Jul; 33(7):481-3. PubMed ID: 7523320
[TBL] [Abstract][Full Text] [Related]
63. The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo.
Norris A; Todd C; Graham A; Quinn AG; Thody AJ
Br J Dermatol; 1996 Feb; 134(2):299-306. PubMed ID: 8746346
[TBL] [Abstract][Full Text] [Related]
64. Pigmented human skin equivalent: new method of reconstitution by grafting an epithelial sheet onto a non-contractile dermal equivalent.
Nakazawa K; Nakazawa H; Sahuc F; Lepavec A; Collombel C; Damour O
Pigment Cell Res; 1997 Dec; 10(6):382-90. PubMed ID: 9428005
[TBL] [Abstract][Full Text] [Related]
65. Impact of ultraviolet radiation on dermal and epidermal DNA damage in a human pigmented bilayered skin substitute.
Goyer B; Pereira U; Magne B; Larouche D; Kearns-Turcotte S; Rochette PJ; Martin L; Germain L
J Tissue Eng Regen Med; 2019 Dec; 13(12):2300-2311. PubMed ID: 31502756
[TBL] [Abstract][Full Text] [Related]
66. Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling.
Martins C; Migayron L; Drullion C; Jacquemin C; Lucchese F; Rambert J; Merhi R; Michon P; Taieb A; Rezvani HR; de Rinaldis E; Seneschal J; Boniface K
J Invest Dermatol; 2022 Apr; 142(4):1194-1205.e7. PubMed ID: 34655610
[TBL] [Abstract][Full Text] [Related]
67. Increased anti-oxidative action compensates for collagen tissue degeneration in vitiligo dermis.
Yokoi K; Yasumizu Y; Ohkura N; Shinzawa K; Okuzaki D; Shimoda N; Ando H; Yamada N; Fujimoto M; Tanemura A
Pigment Cell Melanoma Res; 2023 Sep; 36(5):355-364. PubMed ID: 37230937
[TBL] [Abstract][Full Text] [Related]
68. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo.
Lee AY; Kim NH; Choi WI; Youm YH
J Invest Dermatol; 2005 May; 124(5):976-83. PubMed ID: 15854039
[TBL] [Abstract][Full Text] [Related]
69. Key regulatory role of dermal fibroblasts in pigmentation as demonstrated using a reconstructed skin model: impact of photo-aging.
Duval C; Cohen C; Chagnoleau C; Flouret V; Bourreau E; Bernerd F
PLoS One; 2014; 9(12):e114182. PubMed ID: 25490395
[TBL] [Abstract][Full Text] [Related]
70. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
[TBL] [Abstract][Full Text] [Related]
71. Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo.
Steitz J; Wenzel J; Gaffal E; Tüting T
Eur J Cell Biol; 2004 Dec; 83(11-12):797-803. PubMed ID: 15679123
[TBL] [Abstract][Full Text] [Related]
72. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
Boniface K; Seneschal J; Picardo M; Taïeb A
Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
[TBL] [Abstract][Full Text] [Related]
73. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin.
Prignano F; Pescitelli L; Becatti M; Di Gennaro P; Fiorillo C; Taddei N; Lotti T
J Dermatol Sci; 2009 Jun; 54(3):157-67. PubMed ID: 19282153
[TBL] [Abstract][Full Text] [Related]
74. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma.
Vanscheidt W; Hunziker T
Dermatology; 2009; 218(4):342-3. PubMed ID: 19174603
[TBL] [Abstract][Full Text] [Related]
75. Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival.
Kim NH; Lee AY
Exp Dermatol; 2010 Dec; 19(12):1073-9. PubMed ID: 21054556
[TBL] [Abstract][Full Text] [Related]
76. Melanocyte destruction and repigmentation in vitiligo: a model for nerve cell damage and regrowth.
Yu HS
J Biomed Sci; 2002; 9(6 Pt 2):564-73. PubMed ID: 12432222
[TBL] [Abstract][Full Text] [Related]
77. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir.
Dogra S; Kumar B
Dermatol Online J; 2005 Dec; 11(3):30. PubMed ID: 16409926
[TBL] [Abstract][Full Text] [Related]
78. Combination of epidermal keratinocyte-melanocyte cells suspension and microneedling: Safe surgical approach in vitiligo.
Nilforoushzadeh MA; Nouri M; Alavi S; Sadatiseyedmahaleh A; Razzaghi Z; Khodaverdi Darian E; Afzali H; Mahmoudbeyk M; Behrangi E; Nikkhah N; Peyrovan A; Zare S
J Cosmet Dermatol; 2022 Oct; 21(10):4669-4676. PubMed ID: 35419925
[TBL] [Abstract][Full Text] [Related]
79. Mapping architectural and transcriptional alterations in non-lesional and lesional epidermis in vitiligo.
Singh A; Gotherwal V; Junni P; Vijayan V; Tiwari M; Ganju P; Kumar A; Sharma P; Fatima T; Gupta A; Holla A; Kar HK; Khanna S; Thukral L; Malik G; Natarajan K; Gadgil CJ; Lahesmaa R; Natarajan VT; Rani R; Gokhale RS
Sci Rep; 2017 Aug; 7(1):9860. PubMed ID: 28852211
[TBL] [Abstract][Full Text] [Related]
80. Dissecting Wnt Signaling for Melanocyte Regulation during Wound Healing.
Sun Q; Rabbani P; Takeo M; Lee SH; Lim CH; Noel ES; Taketo MM; Myung P; Millar S; Ito M
J Invest Dermatol; 2018 Jul; 138(7):1591-1600. PubMed ID: 29428355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
